|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 181176-181200 of 2349128 (93966 Page(s) Totally)
<< < 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-01-06T03:11:40Z |
An Open-Framework Aluminophosphite with Face-Sharing AlO6 Octahedra Dimers and Extra-Large 14-Ring Channels
|
Lin, Cong; Pan, Fengjuan; Li, Jian; Chen, Yanping; Shi, Dier; Ma, Tianqiong; Yang, Yanquan; Du, Xin; Wang, Wei; Liao, Fuhui; Lin, Jianhua; Yang, Tao; Sun, Junliang; YAN-PING CHEN |
| 臺大學術典藏 |
2019-12-04T08:44:09Z |
An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption
|
Chia-Yu Chu; CHIA-YU CHU |
| 國立臺灣大學 |
2007 |
An Open-Label Pilot Study to Evaluate the Safety and Efficacy of Topically Applied Pimecrolimus Cream for the Treatment of Steroid-Induced Rosacea-Like Eruption.
|
朱家瑜; CHU, CHIA-YU |
| 國立臺灣大學 |
2007-04 |
An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
|
Chu, CY |
| 國立成功大學 |
2008-09 |
AN OPEN-LABEL SAFETY STUDY OF FIRST-LINE BEVACIZUMAB IN COMBINATION WITH STANDARD CHEMOTHERAPY IN CHINESE PATIENTS WITH METASTATIC COLORECTAL CANCER
|
Lee, K.; Chen, H.; Wang, H.; Tsao, C.; Chiou, C.; Hsu, T.; Su, Wu-Chou; Wang, J. |
| 國立成功大學 |
2013 |
An Open-Label Safety Study of First-Line Bevacizumab in Combination with Standard Chemotherapy in Chinese Patients with Metastatic Colorectal Cancer Treated in an Expanded Access Program in Taiwan
|
Lee, Kuan-Der; Chen, Hong-Hwa; Wang, Hwei-Ming; Tsao, Chao-Jung; Hsu, Tzu-Chi; Chiu, Chang-Fang; Su, Wu-Chou; Wang, Jeng-Yi |
| 國立臺灣大學 |
2009 |
An Open-Label Single-Arm Phase Iv Study of Pemetrexed in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy
|
張基晟; 蔡俊明; 夏德椿; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; HSIA, TE-CHUN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
An Open-Label, Comparative, Multicentre Study of Peginterferon Alfa-2a ( 40kd) Plus Ribavirin in the Treatment of Patients Chronically Infected with Hcv/Hbv or Hcv Alone
|
劉俊人; 莊萬龍; 李全謨; 吳順生; 廖麗瑛; 郭行道; 趙有誠; 陳祈玲; 陳培哲; 陳定信; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; WU, SHUN-SHENG; LIAO, LI-YING; KUO, HSING-TAO; CHAO, YOU-CHEN; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺北醫學大學 |
2002 |
An open-label, crossover study of a new phosphate-binding agent in hemodialysis patients: ferric citrate
|
侯君正; Wu-Chang Yang; Chwei-Shiun Yang; Chun-Cheng Hou; Tsai-Hung Wu; Eric W. Young; Chen H. Hsu |
| 臺大學術典藏 |
2020-05-25T07:35:06Z |
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
|
Abou-Alfa G.K.;Yau T;Ryoo B.-Y;Knox J;Brown J;Kelley R.K;Chao T.-Y;Choi H.J;Freilich B;Modiano M;Yoon J.-H;Chia-Chi Lin;Yong W.P;Lim H.Y;El Dika I; El Dika I; Lim H.Y; Yong W.P; Chia-Chi Lin; Yoon J.-H; Modiano M; Freilich B; Choi H.J; Chao T.-Y; Kelley R.K; Brown J; Knox J; Ryoo B.-Y; Yau T; Abou-Alfa G.K. |
| 亞洲大學 |
2010-01 |
An Open-Label, Multicentre Study of Levocetirizine for the Treatment of Allergic Rhinitis and Urticaria in Taiwanese Patients
|
;Fang, Sheen-Yie;Perng, Diahn-Warng;Lee, J.Yu-Yun;Lin, Ding-Yu;黃志揚;HUANG, CHIH-YANG |
| 中國醫藥大學 |
2010 |
An Open-Label, Multicentre Study of Levocetirizine for the Treatment of Allergic Rhinitis and Urticaria in Taiwanese Patients
|
(Sheen-Yie Fang); (Diahn-Warng Perng); (J. Yu-Yun Lee); (Ding-Yu Lin)*; 黃志揚(Chih-Yang Huang)* |
| 臺大學術典藏 |
2017 |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
|
Ni H.-C.; Lin Y.-J.; SUSAN SHUR-FEN GAU; Huang H.-C.; Yang L.-K. |
| 臺大學術典藏 |
2018-09-10T18:02:04Z |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
|
Ni, H.-C. and Lin, Y.-J. and Gau, S.S.-F. and Huang, H.-C. and Yang, L.-K.; SUSAN SHUR-FEN GAU |
| 臺大學術典藏 |
2020-03-02T03:10:50Z |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
|
Ni H.-C.; Lin Y.-J.; SUSAN SHUR-FEN GAU; Huang H.-C.; Yang L.-K. |
| 臺大學術典藏 |
2015 |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder
|
Shang C.-Y.; Pan Y.-L.; Lin H.-Y.; Huang L.-W.; SUSAN SHUR-FEN GAU |
| 臺大學術典藏 |
2018-09-10T15:24:25Z |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder
|
Shang, C.-Y. and Pan, Y.-L. and Lin, H.-Y. and Huang, L.-W. and Gau, S.S.-F.; HSIANG-YUAN LIN; SUSAN SHUR-FEN GAU; CHI-YUNG SHANG |
| 臺大學術典藏 |
2020-03-02T03:11:01Z |
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder
|
Shang C.-Y.; Pan Y.-L.; Lin H.-Y.; Huang L.-W.; SUSAN SHUR-FEN GAU |
| 臺大學術典藏 |
2018-09-10T06:03:30Z |
An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/ hyperactivity disorder in Taiwan
|
Gau, S.S.-F. and Shen, H.-Y. and Soong, W.-T. and Gau, C.-S.; SUSAN SHUR-FEN GAU |
| 臺大學術典藏 |
2020-03-02T03:11:27Z |
An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/ hyperactivity disorder in Taiwan
|
Susan Shur-Fen Gau;Shen H.-Y.;Soong W.-T.;Gau C.-S.; SUSAN SHUR-FEN GAU; Shen H.-Y.; Soong W.-T.; Gau C.-S. |
| 國立臺灣大學 |
2006-08 |
An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan
|
Gau, SS; Sheng, HY; Soong, WT; Gau, CS |
| 國立成功大學 |
2020 |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistan
|
Huang, C.-F.;Hung, C.-H.;Cheng, P.-N.;Bair, M.-J.;Huang, Y.-H.;Kao, J.-H.;Hsu, S.-J.;Lee, P.-L.;Chen, J.-J.;Chien, R.-N.;Peng, C.-Y.;Lin, C.-Y.;Hsieh, T.-Y.;Cheng, Cheng C.-H.;Dai, C.-Y.;Huang, J.-F.;Chuang, W.-L.;Yu, M.-L. |
| 國立交通大學 |
2019-12-13T01:09:57Z |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions
|
Huang, Chung-Feng; Hung, Chao-Hung; Cheng, Pin-Nan; Bair, Ming-Jong; Huang, Yi-Hsiang; Kao, Jia-Horng; Hsu, Shih-Jer; Lee, Pei-Lun; Chen, Jyh-Jou; Chien, Rong-Nan; Peng, Cheng-Yuan; Lin, Chun-Yen; Hsieh, Tsai-Yuan; Cheng, Chun-Han; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 臺大學術典藏 |
2021-09-04T05:16:42Z |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions
|
Huang C.-F.; Hung C.-H.; Cheng P.-N.; Bair M.-J.; Huang Y.-H.; JIA-HORNG KAO; Hsu S.-J.; Lee P.-L.; Chen J.-J.; Chien R.-N.; Peng C.-Y.; Lin C.-Y.; Hsieh T.-Y.; Cheng C.-H.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Yu M.-L. |
| 國立臺灣大學 |
2013 |
An Open-Label, Randomized, Controlled Trial of Zotepine and Risperidone for Acutely Ill, Hospitalized, Schizophrenic Patients With Symptoms of Agitation
|
Chan, Hung-Yu; Lin, An-Sheng; Chen, Kun-Po; Cheng, Jror-Serk; Chen, Ying-Yeh; Tsai, Chang-Jer |
Showing items 181176-181200 of 2349128 (93966 Page(s) Totally)
<< < 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 > >>
View [10|25|50] records per page
|
